Generic immunosuppression in transplantation: current evidence and controversial issues

S El Hajj, M Kim, K Phillips… - Expert Review of Clinical …, 2015 - Taylor & Francis
The overall success of organ transplantation in the 21st century has been predicated, in part,
on the use of newer, more potent, and selective immunosuppressive agents. However, the …

Development of nifedipine orodispersible tablets by different techniques using natural and synthetic superdisintegrants

K Singh, S Sharma - Research Journal of Pharmacy and …, 2021 - indianjournals.com
The oral delivery of drugs undergoing extensive first-pass metabolism is a tedious task, as
the bioavailability of such agents is severely hampered, resulting in poor pharmacological …

[PDF][PDF] Development and characterization of orodispersible tablets of propranolol hydrochloride using calcium cross-linked cassia fistula gum and cross carmellose …

K SINGH, S SHARMA - Int J App Pharm, 2020 - academia.edu
Objective: The present investigation was aimed towards developing calcium crosslinked
derivative of carboxymethylated cassia fistula gum and crosscarmellose sodium based …

[PDF][PDF] Atenolol And Nifedipine Combination Is Better Than Monotherapy: A New Era In Novel Drug Delivery For Hypertension

Hypertension is considered a major health problems globally affect millions of patient.
Various study confirms that single drug treatment usually is not adequate to achieve blood …

L'utilisation de génériques en transplantation: vers des solutions rationnelles et sures!

J Rottembourg, G Rostoker - La Presse Médicale, 2018 - Elsevier
Résumé Des médicaments immunosuppresseurs génériques sont désormais disponibles
en Europe, au Canada et aux États-Unis. Il existe selon les pays de larges différences dans …